Growth Metrics

Enanta Pharmaceuticals (ENTA) Free Cash Flow Growth (3y) (2015 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Growth (3y) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 24.91%
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - 20.11%
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 14.71%
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -10.65%
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 31.42%
10 Enanta Pharmaceuticals 367.22 Mn 203.44 Mn - 23.73%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 23.73%
Dec 31, 2025 32.67%
Sep 30, 2025 -3.85%
Jun 30, 2025 42.89%
Mar 31, 2025 15.72%
Dec 31, 2024 -24.25%
Sep 30, 2024 -0.27%
Jun 30, 2024 13.75%
Mar 31, 2024 -85.93%
Dec 31, 2023 -19.57%
Sep 30, 2023 -14.38%
Jun 30, 2023 -94.23%
Mar 31, 2023 -45.40%
Dec 31, 2022 -73.99%
Sep 30, 2022 -58.04%
Jun 30, 2022 -364.97%
Mar 31, 2022 -43.24%
Dec 31, 2021 -34.99%
Sep 30, 2021 -40.42%
Jun 30, 2021 -96.42%
Mar 31, 2021 18.58%
Dec 31, 2020 -76.60%
Sep 30, 2020 -31.40%
Jun 30, 2020 5.46%
Mar 31, 2020 83.76%
Dec 31, 2019 75.63%
Sep 30, 2019 74.22%
Jun 30, 2019 28.29%
Mar 31, 2019 49.43%
Dec 31, 2018 1.37%
Sep 30, 2018 109.20%
Jun 30, 2018 33.11%
Mar 31, 2018 -27.82%
Dec 31, 2017 39.81%
Sep 30, 2017 132.30%
Jun 30, 2017 -29.25%
Mar 31, 2017 5.71%
Dec 31, 2016 33.36%
Sep 30, 2016 37.10%
Jun 30, 2016 23.02%
Mar 31, 2016 -4.13%
Dec 31, 2015 45.45%
Sep 30, 2015 -29.69%
Jun 30, 2015 -55.62%